The definition of biochemical failure in patients treated with definitive radiotherapy
Authors:
- Michael W KattanMKMichael W Kattan
- Paul A FearnPFPaul A Fearn
- Steven LeibelSLSteven Leibel
- Louis PottersLPLouis Potters
- 1 December 2000
- journal article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 48 (5) , 1469-1474
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- PROSTATE SPECIFIC ANTIGEN BOUNCE AFTER RADIOACTIVE SEED IMPLANTATION FOLLOWED BY EXTERNAL BEAM RADIATION FOR PROSTATE CANCERJournal of Urology, 2000
- Scrutiny of the ASTRO consensus definition of biochemical failure in irradiated prostate cancer patients demonstrates its usefulness and robustnessInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
- Caution in interpreting biochemical control rates after treatment for prostate cancer: length of follow-up influences resultsUrology, 1999
- The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999
- The Correlation Between the Astro Consensus Panel Definition of Biochemical Failure and Clinical Outcome for Patients with Prostate Cancer Treated with External Beam IrradiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1998
- Prostate-specific antigen nadir of 0.5 ng/ml or less defines disease freedom for surgically staged men irradiated for prostate cancerUrology, 1997
- Evaluation of a Nomogram used to predict the pathologic stage of clinically localized prostate carcinomaCancer, 1997
- Prostate-specific antigen nadir: the optimum level after irradiation for prostate cancer.Journal of Clinical Oncology, 1996